Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hamza, Lasla"'
Autor:
Anne Clavreul, Catherine Guette, Hamza Lasla, Audrey Rousseau, Odile Blanchet, Cécile Henry, Alice Boissard, Mathilde Cherel, Pascal Jézéquel, François Guillonneau, Philippe Menei, Jean‐Michel Lemée
Publikováno v:
Molecular Oncology, Vol 18, Iss 11, Pp 2783-2800 (2024)
Proteomics has been little used for the identification of novel prognostic and/or therapeutic markers in isocitrate dehydrogenase (IDH)‐wildtype glioblastoma (GB). In this study, we analyzed 50 tumor and 30 serum samples from short‐ and long‐te
Externí odkaz:
https://doaj.org/article/ae94e9b8701f4895ae70d006bc3eb111
Autor:
Steven Lohard, Nathalie Bourgeois, Laurent Maillet, Fabien Gautier, Aurélie Fétiveau, Hamza Lasla, Frédérique Nguyen, Céline Vuillier, Alison Dumont, Agnès Moreau-Aubry, Morgane Frapin, Laurent David, Delphine Loussouarn, Olivier Kerdraon, Mario Campone, Pascal Jézéquel, Philippe P. Juin, Sophie Barillé-Nion
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Antimitotic compounds, such as paclitaxel, induce cell death in cycling cancer cells only. Here, the authors show that paclitaxel-targeted breast cancer cells prime neighboring cells to apoptosis through a STING-mediated paracrine signaling pathway.
Externí odkaz:
https://doaj.org/article/0aa8ad60806d444b913612a87eb4037b
Autor:
Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, Wilfried Gouraud, Jean-Luc Canon, Andrea Gombos, Florence Dalenc, Suzette Delaloge, Jérôme Lemonnier, Delphine Loussouarn, Véronique Verrièle, Mario Campone
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-14 (2019)
Abstract Background Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are requ
Externí odkaz:
https://doaj.org/article/c9a534fbdbec4c00829a348e951a5380
Autor:
Agnes Basseville, Chiara Cordier, Fadoua Ben Azzouz, Wilfried Gouraud, Hamza Lasla, Fabien Panloup, Mario Campone, Pascal Jézéquel
Publikováno v:
Cancer Research Communications. 2:857-869
Heterogeneity of the tumor microenvironment (TME) is one of the major causes of treatment resistance in breast cancer. Among TME components, nervous system role in clinical outcome has been underestimated. Identifying neuronal signatures associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cf56f2c2669969014237f81c5ea27bf
https://doi.org/10.1158/2767-9764.crc-21-0090
https://doi.org/10.1158/2767-9764.crc-21-0090
Autor:
Pascal Jézéquel, Mario Campone, Fabien Panloup, Hamza Lasla, Wilfried Gouraud, Fadoua Ben Azzouz, Chiara Cordier, Agnes Basseville
Heterogeneity of the tumor microenvironment (TME) is one of the major causes of treatment resistance in breast cancer. Among TME components, nervous system role in clinical outcome has been underestimated. Identifying neuronal signatures associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0008fb7e2ffa5e37fb8c67dffd9b38f2
https://doi.org/10.1158/2767-9764.c.6550791
https://doi.org/10.1158/2767-9764.c.6550791
Autor:
Pascal Jézéquel, Mario Campone, Fabien Panloup, Hamza Lasla, Wilfried Gouraud, Fadoua Ben Azzouz, Chiara Cordier, Agnes Basseville
Supplementary Table S1: R package referencesSupplementary Table S2: Merged Affymetrix cohort patient characteristicsSupplementary Table S3: Validation cohort patient characteristicsSupplementary Table S4: Algorithm parameter optimizationSupplementary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8414f766d4bfc10a08d34952c588127
https://doi.org/10.1158/2767-9764.22544928.v1
https://doi.org/10.1158/2767-9764.22544928.v1
Autor:
Hamza Lasla, Mario Campone, Philippe Juin, Pascal Jézéquel, Agnes Basseville, Fadoua Ben Azzouz, Wilfried Gouraud
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2021, 108 (11), pp.1057-1064. ⟨10.1016/j.bulcan.2021.05.008⟩
Bulletin du Cancer, 2021, 108 (11), pp.1057-1064. ⟨10.1016/j.bulcan.2021.05.008⟩
We are taking advantage of the launch of the latest version (v4.6) of our web-based data mining tool "breast cancer gene-expression miner" (bc-GenExMiner) to take stock of its position within the oncology research landscape and to present an activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4748b4142be4b42577c8fe52060bf15d
https://doi.org/10.1016/j.bulcan.2021.05.008
https://doi.org/10.1016/j.bulcan.2021.05.008
Autor:
Clément Bouron, Clara Mathie, Valérie Seegers, Olivier Morel, Pascal Jézéquel, Hamza Lasla, Camille Guillerminet, Sylvie Girault, Marie Lacombe, Avigaelle Sher, Franck Lacoeuille, Anne Patsouris, Aude Testard
Publikováno v:
Cancers, Vol 14, Iss 637, p 637 (2022)
Cancers
Cancers, 2022, 14 (3), pp.637. ⟨10.3390/cancers14030637⟩
Cancers; Volume 14; Issue 3; Pages: 637
Cancers
Cancers, 2022, 14 (3), pp.637. ⟨10.3390/cancers14030637⟩
Cancers; Volume 14; Issue 3; Pages: 637
(1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d105257dfdb23d8d1188ad1f015fbd
https://www.mdpi.com/2072-6694/14/3/637
https://www.mdpi.com/2072-6694/14/3/637
Autor:
Jean Sebastien FRENEL, Fadoua Ben Azzouz, Frederic Bigot, Jonathan Dauve, Marie Francoise Heymann, Wilfried Gouraud, Catherine Guette, Hamza Lasla, Bertrand Michel, Alain Morel, Anne Patsouris, Marie Robert, Grégoire Siekaniec, Mathilde Colombie, Pascal Jézéquel, Mario Campone
Publikováno v:
Cancer Research. 83:P5-02
CONTEXT: Endocrine therapy combined with CDK4/6 inhibitor is the standard frontline treatment for the vast majority of HR+/HER2- MBC patients. Despite an overall survival benefit, patients eventually progress and mechanisms of resistance to this comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4d004a203ffabe0c2be8efe696224e7
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-37
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-37
Autor:
Clément, Bouron, Clara, Mathie, Valérie, Seegers, Olivier, Morel, Pascal, Jézéquel, Hamza, Lasla, Camille, Guillerminet, Sylvie, Girault, Marie, Lacombe, Avigaelle, Sher, Franck, Lacoeuille, Anne, Patsouris, Aude, Testard
Publikováno v:
Cancers. 14(3)
(1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdd74ec5dbcabcd2d6fb91de75af8676
https://pubmed.ncbi.nlm.nih.gov/35158904
https://pubmed.ncbi.nlm.nih.gov/35158904